Matsumoto A K, Kopicky-Burd J, Carter R H, Tuveson D A, Tedder T F, Fearon D T
Division of Molecular and Clinical Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
J Exp Med. 1991 Jan 1;173(1):55-64. doi: 10.1084/jem.173.1.55.
The complement system augments the humoral immune response, possibly by a mechanism that involves the B lymphocyte membrane receptor, CR2, which binds the C3dg fragment of C3 and triggers several B cell responses in vitro. The present study demonstrates that CR2 associates with a complex of membrane proteins that may mediate signal transduction by ligated CR2. Monoclonal antibodies to CR2 immunoprecipitated from digitonin lysates of Raji B lymphoblastoid cells a membrane complex containing CR2, approximately equimolar amounts of CD19, which is a member of the immunoglobulin superfamily, and three unidentified components: p130, p50, and p20. The complex, which was immunoprecipitated also with anti-CD19, could be dissociated by Nonidet P-40, accounting for its absence in previous studies of CR2. Expression of recombinant CR2 and CD19 in K562 erythroleukemia cells led to formation of a complex that contained not only these two proteins but also p130, p50, and p20, and another component, p14. These unidentified components of the CR2/CD19 complex coimmunoprecipitated with CD19 and not with CR2 from singly transfected cells, indicating primary association with the former. CD19 replicated the capacity of CR2 to interact synergistically with mIgM for increasing free intracellular Ca2+, suggesting that the complex mediates this function of CR2. Therefore, CR2 associates directly with CD19 to become a ligand-binding subunit of a pre-existing signal transduction complex of the B cell that may be representative of a family of membrane protein complexes. This interaction between the complement and immune systems differs from that between immunoglobulin and Clq by involving membrane rather than plasma proteins, and by having complement involved in the afferent phase of the immune response.
补体系统增强体液免疫反应,其机制可能涉及B淋巴细胞膜受体CR2,该受体可结合C3的C3dg片段并在体外触发多种B细胞反应。本研究表明,CR2与一组膜蛋白复合物相关联,该复合物可能介导CR2连接后的信号转导。从Raji B淋巴母细胞的洋地黄皂苷裂解物中免疫沉淀出的抗CR2单克隆抗体,形成了一种膜复合物,其中含有CR2、等量的免疫球蛋白超家族成员CD19以及三种未鉴定成分:p130、p50和p20。该复合物也可用抗CD19进行免疫沉淀,可被Nonidet P - 40解离,这解释了其在先前CR2研究中未被发现的原因。在K562红白血病细胞中表达重组CR2和CD19导致形成一种复合物,该复合物不仅包含这两种蛋白质,还包含p130、p50和p20以及另一种成分p14。CR2/CD19复合物的这些未鉴定成分与CD19共免疫沉淀,而不是与单转染细胞中的CR2共沉淀,表明它们主要与前者相关联。CD19复制了CR2与mIgM协同作用以增加细胞内游离Ca2+的能力,表明该复合物介导了CR2的这一功能。因此,CR2直接与CD19结合,成为B细胞预先存在的信号转导复合物的配体结合亚基,该复合物可能代表了一类膜蛋白复合物。补体系统与免疫系统之间的这种相互作用不同于免疫球蛋白与Clq之间的相互作用,前者涉及膜蛋白而非血浆蛋白,并且补体参与免疫反应的传入阶段。